Pediatric Neurosurgery Team
Cormac Maher, MD
Professor, Neurosurgery
Division Chief, Pediatric Neurosurgery
Dr. Maher is a Pediatric Neurosurgeon with clinical interest in surgical treatment of Chiari Malformation, arteriovenous malformations, Moyamoya disease, cavernous malformations, pediatric brain tumors, spinal dysraphism, tethered spinal cord, and hydrocephalus. Dr. Maher attended medical school at Georgetown University. He completed a surgical internship and neurosurgical residency at the Mayo Clinic in Rochester, Minnesota. After residency, he completed a in pediatric neurosurgery fellowship at Boston Children's Hospital under the direction of R. Michael Scott, M.D. Afterward, he completed a fellowship in cerebrovascular neurosurgery at the Brigham & Women's Hospital.
Kelly Mahaney, MD
Assistant Professor, Neurosurgery
Dr. Mahaney is a Pediatric Neurosurgeon with clinical interest in Hydrocephalus, Craniovertebral Junction abnormalities, Spasticity, Spinal dysraphism and Myelomeningocele, Central Nervous System tumors, and Pediatric Epilepsy surgery. She completed residency training at the University of Iowa Hospitals and Clinics and subspecialty Pediatric Neurosurgery training at The Hospital for Sick Children in Toronto and the Barrow Neurologic Institute at Phoenix Children's Hospital. She is interested in advancing Neuro-endoscopic techniques in Pediatric Neurosurgical practice. Dr. Mahaney's research focuses on delineating the role of iron in the development of post-hemorrhagic hydrocephalus.
Laura Prolo, MD, PhD
Assistant Professor, Neurosurgery
Dr. Prolo received her MD/PhD in Neuroscience at Stanford University and trained as a Neurosurgery resident at Stanford University Medical Center. She completed her fellowship in Pediatric Neurosurgery at University of Washington/Seattle Children’s Hospital. Her clinical focus is on brain and spinal cord tumors, craniosynostosis, Chiari malformation, Moyamoya Disease, spinal dysraphism and genetically targeted therapies for inherited disorders of the nervous system. Dr. Prolo’s research program is focused on advancing and applying evolving molecular technologies for the diagnosis, characterization and treatment of children with brain tumors and congenital disorders.
